Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer

被引:42
作者
Lei, HuiFang [1 ,2 ]
Xu, ShuXia [3 ]
Mao, XiaoDan [1 ,2 ]
Chen, XiaoYing [4 ]
Chen, YaoJia [1 ,2 ]
Sun, XiaoQi [4 ]
Sun, PengMing [1 ,2 ,4 ]
机构
[1] Fujian Med Univ, Affiliated Hosp, Fujian Prov Matern & Childrens Hosp, Dept Gynecol,Lab Gynecol Oncol, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp, Fujian Prov Matern & Childrens Hosp, Fujian Key Lab Women & Childrens Crit Dis Res, Fuzhou, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp, Fujian Prov Matern & Childrens Hosp, Dept Pathol, Fuzhou, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp, Fujian Prov Matern & Childrens Hosp, Dept Gynecol, Fuzhou, Peoples R China
关键词
systemic immune-inflammatory index; neutrophil; platelet; lymphocyte count; lymph node metastasis; endometrial cancer; LYMPHADENECTOMY; CARCINOMA;
D O I
10.2147/JIR.S345790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study assessed the predictive value of the preoperative systemic immune inflammatory index (SII) for lymph node metastasis (LNM) in endometrial cancer (EC) patients. Methods: We retrospectively included 392 EC patients between January 2013 and January 2019. Data on clinical indicators including age, body mass index (BMI), menopause, serum inflammatory immune index, serum tumor markers, history of diabetes and hypertension, stage, histological type, and myometrial invasion (MI) were collected. The association between clinical indicators and LNM was evaluated. Results: The results indicated that neutrophil (NE), monocyte (MO) counts, SII, cancer antigen 125 (CA125), cancer antigen 153 (CA153), cancer antigen 199 (CA199), and the expression of estrogen receptor (ER) and Ki67 were higher in EC patients with LNM than in those without LNM (P<0.05). Lymph vascular space invasion (LVSI) was also associated with LNM (P<0.05). Consequently, the SII, CA125, CA153 and LVSI were found to be independent risk factors for LNM, and a nomogram including these indicators was performed. The ROC curve analysis showed that compared with a single index, the combination of the SII, CA125, CA153 and LVSI significantly improved the efficiency of diagnosing LNM in EC patients (AUC=0.865, P < 0.001). Moreover, the SII was significantly associated with age, menopause, and FIGO stage (P < 0.05). Further logistic regression analysis suggested that elevated serum SII was an independent risk factor for MI and progression to a higher pathological grade in young premenopausal EC patients. In addition, elevated SII was an independent risk factor for advanced EC progression in age >= 55 or postmenopausal EC patients. Conclusion: An elevated SII is an independent risk factor for LNM in patients with EC. In addition, the SII can be used as a predictor of MI and higher pathological grade in young premenopausal EC patients.
引用
收藏
页码:7131 / 7142
页数:12
相关论文
共 33 条
[1]   Cancer of the corpus uteri [J].
Amant, Frederic ;
Mirza, Mansoor Raza ;
Koskas, Martin ;
Creutzberg, Carien L. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 :37-50
[2]   Immunity, inflammation and cancer: a leading role for adenosine [J].
Antonioli, Luca ;
Blandizzi, Corrado ;
Pacher, Pal ;
Hasko, Gyoergy .
NATURE REVIEWS CANCER, 2013, 13 (12) :842-857
[3]   Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients [J].
Aoyama, Tadashi ;
Takano, Masashi ;
Miyamoto, Morikazu ;
Yoshikawa, Tomoyuki ;
Kato, Kento ;
Sakamoto, Takahiro ;
Takasaki, Kazuki ;
Matsuura, Hiroko ;
Soyama, Hiroaki ;
Hirata, Junko ;
Suzuki, Ayako ;
Sasa, Hidenori ;
Tsuda, Hitoshi ;
Furuya, Kenichi .
ONCOLOGY, 2019, 96 (05) :259-267
[4]   Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type I and Type II Endometrial Cancer [J].
Burgess, Brian ;
Levine, Beverly ;
Taylor, Robert N. ;
Kelly, Michael G. .
REPRODUCTIVE SCIENCES, 2020, 27 (01) :194-203
[5]   Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer [J].
Chen, Hao ;
Wu, Qijun ;
Zhang, Yunzheng ;
Li, Qing ;
Ma, Jian ;
Kong, Fanfei ;
Ma, Xiaoxin .
GYNECOLOGIC ONCOLOGY, 2020, 158 (03) :689-697
[6]   Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer [J].
Cragun, JM ;
Havrilesky, LJ ;
Calingaert, B ;
Synan, I ;
Secord, AA ;
Soper, JT ;
Clarke-Pearson, DL ;
Berchuck, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3668-3675
[7]   Revised FIGO staging for carcinoma of the endometrium [J].
Creasman, William .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 105 (02) :109-109
[8]   Inflammation and cancer: advances and new agents [J].
Crusz, Shanthini M. ;
Balkwill, Frances R. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (10) :584-596
[9]   Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection [J].
Deng, Yuxiang ;
Zhao, Yujie ;
Qin, Jiayi ;
Huang, Xiaozhen ;
Wu, Ruomei ;
Zhou, Caixia ;
Pan, Zhizhong .
PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
[10]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503